Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 77,300 | 95,300 | 112,000 | 360,300 | N/A |
| Depreciation Amortization | 226,200 | 215,400 | 213,500 | 194,100 | N/A |
| Income taxes - deferred | -7,500 | -1,100 | -20,200 | -6,100 | N/A |
| Accounts receivable | -21,400 | 4,200 | -22,000 | 9,200 | N/A |
| Accounts payable and accrued liabilities | -36,100 | 36,500 | -23,500 | 15,000 | N/A |
| Other Working Capital | -51,000 | 44,100 | -73,700 | 265,400 | N/A |
| Other Operating Activity | 71,900 | 16,400 | 84,800 | -384,500 | 0 |
| Operating Cash Flow | $259,400 | $410,800 | $270,900 | $453,400 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -63,700 | -108,000 | -128,100 | -73,800 | N/A |
| Net Acquisitions | -84,900 | -2,500 | -209,900 | 27,100 | N/A |
| Purchase Of Investment | N/A | 0 | N/A | -1,100 | N/A |
| Sale Of Investment | 66,000 | N/A | N/A | 347,600 | N/A |
| Other Investing Activity | -100 | 0 | -500 | 0 | 0 |
| Investing Cash Flow | $-82,700 | $-110,500 | $-338,500 | $299,800 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 275,000 | 390,200 | 218,900 | N/A | N/A |
| Debt Repayment | -209,300 | -402,700 | -227,700 | -22,600 | N/A |
| Common Stock Issued | 800 | 100 | 500 | 15,600 | N/A |
| Common Stock Repurchased | -900 | -400 | N/A | -400 | N/A |
| Dividend Paid | -327,100 | -110,800 | -184,200 | -485,100 | N/A |
| Other Financing Activity | -38,000 | -18,800 | -4,900 | 12,300 | 0 |
| Financing Cash Flow | $-299,500 | $-142,400 | $-197,400 | $-480,200 | $N/A |
| Beginning Cash Position | 328,100 | 170,200 | 435,200 | 162,200 | N/A |
| End Cash Position | 205,300 | 328,100 | 170,200 | 435,200 | N/A |
| Net Cash Flow | $-122,800 | $157,900 | $-265,000 | $273,000 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 259,400 | 410,800 | 270,900 | 453,400 | N/A |
| Capital Expenditure | -98,400 | -108,800 | -131,700 | -114,400 | N/A |
| Free Cash Flow | 161,000 | 302,000 | 139,200 | 339,000 | 0 |